Underestimation of risk : Conversely, they may underestimate the risk in some individuals taking GLP-1s, where varied responses to treatment may lead to diverging outcomes
Back Deacon, DF, Johnsen, AH, Holst, JJ (March 1995) 'Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo', Journal Clinical Endocrinology Metabolism , 80/3, 952-7
doi:10.1056/NEJMoa1307684 22
For open access, the authors have applied a Creative Commons Attribution 4.0 International (CC BY 4.0) licence to any Author Accepted Manuscript version arising from this submission
GHK-Cu: The Anti-Aging Copper Peptide with Over 100 Published Studies Durham Peptides Mar 27 3 min read Updated: Apr 5 In a field dominated by large, complex peptides, GHK-Cu stands out as remarkably small just three amino acids and a copper ion